Cmc Icos Biologics, Inc.

Calculating rank

USPTO Granted Patents = 4

CIPO Patents = 1

EPO Patents = 1

Trademarks = 1

Forward Citations = 1

Loading Chart...

2 inventors (with patents filed for the assignee):

Howard R Clarke (3 out of 3 patents)

Howard Robert Grahame Clarke (1 out of 1 patent)

Howard Robert Clarke (0 patent)

4 patents: Sort by Forward Citations

1. 10066231 - Methods for improving recombinant protein expression (2018-09-04),

2. 9957525 - Recombinant protein expression using a hybrid CHEF1 promoter (2018-05-01),

3. 9297024 - Recombinant protein expression using a hybrid CHEF1 promoter (2016-03-29),

4. 9212367 - Methods for improving recombinant protein expression (2015-12-15),

Company Overview

CMC ICOS Biologics, Inc. is a leading contract development and manufacturing organization specializing in the development and production of biopharmaceuticals. With state-of-the-art facilities and a team of experienced professionals, we offer a wide range of services including process development, analytical development, and manufacturing of biologics from early stages to commercialization. Our goal is to provide high-quality solutions to our clients while maintaining a focus on innovation and efficiency.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#75 in Bothell, WA

#1,464 in Washington

#60,671 in US

Bothell, WA, United States of America

Cmc Icos Biologics, Inc.

Forward Citations = 1

2 inventors:

Howard R Clarke (3 out of 3 patents)

Howard Robert Grahame Clarke (1 out of 1 patent)

Howard Robert Clarke (0 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cmc Icos Biologics, Inc.. Retrieved from https://idiyas.com/company/cmc-icos-biologics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]